New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Red Light Holland Corp.
TRIP.CN
Shape
US Flag

CNQ

Unprofitable

EPS improving

Unprofitable

EPS improving

14M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Nov 2024

14M

Drug Manufacturers - Specialty & Generic

Next Earning date - 27 Nov 2024

0.04CAD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-87%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

53%

Quote Panel

Shape
Updated October 24, 2024
1W 0.00 % 1M -17.65 % 3M -22.22 % 1Y -36.36 %

Key Metrics

Shape
  • Market Cap

    13.97M


  • Shares Outstanding

    399.04M


  • Share in Float

    373.66M


  • Dividende

    0


  • Earning Date

    27 Nov 2024


  • Price Target

    0.035


  • Average Volume

    278160


  • Beta

    1.476


  • Range

    0.03-0.075


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.redlighttruffles.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.73x

P/S Ratio

0.70x

P/B Ratio

0.0

Debt/Equity

-140.4%

Net Margin

$-0.0

EPS

How TRIP.CN compares to sector?

P/E Ratio

Relative Strength

Shape

TRIP.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$7M

Shape350%

2025-Revenue

0

$4M

Shape-194%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.02
vs NA

Q2.22

arrow
arrow

N/A

-0.00
vs -0.01

Q3.22

arrow
arrow

N/A

-0.00
vs -0.01

Q4.22

arrow
arrow

N/A

-0.00
vs -0.00

Q1.23

arrow
arrow

N/A

-0.00
vs -0.02

Q2.23

arrow
arrow

N/A

-0.00
vs -0.00

Q3.23

arrow
arrow

N/A

-0.00
vs -0.00

Q4.23

arrow
arrow

N/A

-0.00
vs -0.00

Q1.24

arrow
arrow

N/A

-0.01
vs -0.00

Q2.24

arrow
arrow

+100%

NA
vs -0.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+549%

622.5K  vs 95.9K

Q2.22

arrow
arrow

+32%

785.1K  vs 595.1K

Q3.22

arrow
arrow

+52%

736.4K  vs 485.7K

Q4.22

arrow
arrow

+89%

1.2M  vs 622.2K

Q1.23

arrow
arrow

+101%

1.3M  vs 622.5K

Q2.23

arrow
arrow

+53%

1.2M  vs 785.1K

Q3.23

arrow
arrow

+34%

983.3K  vs 736.4K

Q4.23

arrow
arrow

+10%

1.3M  vs 1.2M

Q1.24

arrow
arrow

+2%

1.3M  vs 1.3M

Q2.24

arrow
arrow

+30%

1.6M  vs 1.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.05

Q4.22

arrow
arrow

-5%

-0.05
vs -0.05

Q1.23

arrow
arrow

-5%

-0.05
vs -0.05

Q2.23

arrow
arrow

-7%

-0.07
vs -0.05

Q3.23

arrow
arrow

-4%

-0.04
vs -0.07

Q4.23

arrow
arrow

-5%

-0.05
vs -0.04

Q1.24

arrow
arrow

-17%

-0.17
vs -0.05

Q2.24

arrow
arrow

-7%

-0.07
vs -0.17

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News